Minako Yamamura

Treatment of Retinoblastoma 1–Intact Hepatocellular Carcinoma With Cyclin‐Dependent Kinase 4/6 Inhibitor Combination Therapy

Jindan Sheng, Susumu Kohno, Nobuhiro Okada et al. · Hepatology · 2021 · 38 citations

Medicine, Oncology, Pharmacology +17

The PD‐1/PD‐L1 axis may be aberrantly activated in occupational cholangiocarcinoma

Yasunori Sato, Masahiko Kinoshita, Shigekazu Takemura et al. · Pathology International · 2017 · 33 citations

Medicine, Oncology, Pathology +15

Diversity in cell differentiation, histology, phenotype and vasculature of mass‐forming intrahepatic cholangiocarcinomas

Hiep Nguyen Canh, Kenta Takahashi, Minako Yamamura et al. · Histopathology · 2021 · 33 citations

Medicine, Oncology, Pathology +11

The cyclin‑dependent kinase pathway involving CDK1 is a potential therapeutic target for cholangiocarcinoma

Minako Yamamura, Yasunori Sato, Kenta Takahashi et al. · Oncology Reports · 2019 · 24 citations · Full text

Medicine, Cell Biology, Oncology +12

Immunosuppressive tumor microenvironment in occupational cholangiocarcinoma: Supportive evidence for the efficacy of immune checkpoint inhibitor therapy

Yasunori Sato, Shogo Tanaka, Masahiko Kinoshita et al. · Journal of Hepato-Biliary-Pancreatic Sciences · 2020 · 18 citations

Medicine, Immunology, Oncology +17